Bristol Myers’ lead deal negotiator to depart after inking series of multibillion-dollar acquisitions

Eliz­a­beth Mi­ly, the lead ac­qui­si­tion and deal ne­go­tia­tor at Bris­tol My­ers Squibb, is leav­ing the Big Phar­ma, a spokesper­son con­firmed to End­points News on Fri­day morn­ing.

Since join­ing Bris­tol My­ers in the spring of 2020 as EVP of strat­e­gy and busi­ness de­vel­op­ment, Mi­ly had helped or­ches­trate a trio of multi­bil­lion-dol­lar ac­qui­si­tions, two of which have beefed up the phar­ma gi­ant’s on­col­o­gy port­fo­lio and an­oth­er that has spurred its push in car­dio­vas­cu­lar dis­eases.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.